FDG PET/CT Imaging in canine cancer patients

Veterinary Radiology and Ultrasound

Volumn 52, Issue 2, 2011, Pages 201-206

  Hansen, Anders E ^a   Mcevoy, Fintan ^a   Engelholm, Svend A ^b   Law, Ian ^b   Kristensen, Annemarie T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Flourodeoxyglucose; Oncology; PET CT

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ANIMAL; ANIMAL DISEASE; ARTICLE; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; DOG; DOG DISEASE; HEART; KIDNEY CORTEX; LIVER; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REFERENCE VALUE; SCINTISCANNING; SKELETAL MUSCLE; SPLEEN; SUBMANDIBULAR GLAND;

ANIMALS; BRAIN; DOG DISEASES; DOGS; FLUORODEOXYGLUCOSE F18; HEART; KIDNEY CORTEX; LIVER; MUSCLE, SKELETAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; SPLEEN; SUBMANDIBULAR GLAND; TOMOGRAPHY, X-RAY COMPUTED;

CANIS FAMILIARIS;

EID: 79952463764     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2010.01757.x     Document Type: Article

References (33)

1. Alford R, Ogawa M, Choyke PL, Kobayashi H. Molecular probes for the in vivo imaging of cancer. Mol Biosyst 2009;5:1279-1291.
2. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683-693.
3. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354:496-507.
4. Paul R, Johansson R, Kiuru A, et al. Imaging of canine cancers with 18F-2-fluoro-2-deoxy-d-glucose (FDG) suggests further applications for cancer imaging in man. Nucl Med Commun 1984;5:641-646.
5. Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 2005;33:145-155.
6. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008;7:11-20.
7. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008;134:703-707.
8. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
9. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37:181-200.
10. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med 1995;36:883-887.
11. Bassett CL, Daniel GB, Legendre AM, Bochsler PN, Smith GT. Characterization of uptake of 2-deoxy-2-[18F] fluoro-d-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease. Mol Imaging Biol 2002;4:201-207.
12. Matwichuk CL, Daniel GB, Bowman LA, Legendre AM, Smith GT. Fluorine-18 fluorodeoxyglucose accumulation in blastomyces dermatitidis-associated inflammation in a dog. Clin Positron Imaging 1999;2:217-221.
13. Smith GT, Hubner KF, Legendre AM, Matwichuk CL, Daniel GB. FDG accumulation in disseminated blastomyces dermatitidis in a dog. Clin Positron Imaging 1998;1:261.
14. Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-358.
15. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
16. Li TR, Tian JH, Wang H, Chen ZQ, Zhao CL. Pitfalls in positron emission tomography/computed tomography imaging: causes and their classifications. Chin Med Sci J 2009;24:12-19.
17. LeBanc AK, Jakoby B, Townsend DW, Daniel GB. Thoracic and abdominal organ uptake of 2-deoxy-2-[18F]fluoro-d-glucose (18FDG) with positron emission tomography in the normal dog. Vet Radiol Ultrasound 2008;49:182-188.
18. Bassett CL, Daniel GB, Bochsler PN, Legendre AM, Smith GT. Characterization of uptake of 2-deoxy-2-[18F]fluoro-d-glucose by fungal-associated inflammation: the differential uptake ratio for blastomyces-associated lesions is as high as for lymphoma and higher than for turpentine abscesses in experimentally induced lesions in rats. Mol Imaging Biol 2002;4:193-200.
19. Eom KD, Lim CY, Gu SH, et al. Positron emission tomography features of canine necrotizing meningoencephalitis. Vet Radiol Ultrasound 2008;49:595-599.
20. Kang BT, Park C, Yoo JH, et al. 18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of primary intracranial histiocytic sarcoma in a dog. J Vet Med Sci 2009;71:1397-1401.
21. LeBlanc AK, Jakoby BW, Townsend DW, Daniel GB. 18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor. Vet Radiol Ultrasound 2009;50:215-223.
22. Lee MS, Ko J, Lee AR, et al. Effects of anesthetic protocol on normal canine brain uptake of 18-FDG assessed by PET/CT. Vet Radiol Ultrasound 2010;51:130-135.
23. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-1839.
24. Roedl JB, Colen RR, King K, Fischman AJ, Mueller PR, Blake MA. Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions. Am J Roentgenol 2008;191:515-521.
25. Varrone A, Asenbaum S, Vander Borght T, et al. EANM procedure guidelines for PET brain imaging using [(18)F]FDG, version 2. Eur J Nucl Med Mol Imaging 2009;36:2103-2110.
26. Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50 (Suppl 1):11S-20S.
27. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34:392-404.
28. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77.
29. Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. Am J Roentgenol 1997;169:1675-1680.
30. Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 2005;26:671-687.
31. Chen WP, Matsunari I, Noda A, et al. Rapid scanning protocol for brain (18)F-FDG PET: a validation study. J Nucl Med 2005;46:1633-1641.
32. Cohade C, Mourtzikos KA, Wahl RL. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 2003;44:1267-1270.
33. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med 2003;44:170-176.